Medicare Enrolled
Dr. Ravi Patel, MD, MBA, FACP, FAHA
Neurology · Apple Valley, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Ravi Patel is a neurology specialist in Apple Valley, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 1,235 Medicare services across 724 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $9,576 from 57 pharmaceutical and/or device companies across 513 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 28% volume in CA
$9,576 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,235
Medicare services
Top 28% in CA for neurology
724
Unique beneficiaries
$132
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~73 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
352 | $73 | $159 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
160 | $66 | $150 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
154 | $81 | $200 |
| EEG monitoring, 12-26 hours This procedure involves monitoring brain wave activity using an electroencephalogram (EEG) for a duration of 12 to 26 hours. |
127 | $247 | $500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
118 | $135 | $324 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
61 | $376 | $553 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $92 | $226 |
| Continuous EEG brain wave monitoring A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously. |
43 | $220 | $500 |
| EEG monitoring, 61-84 hours with review This procedure involves continuous monitoring of brain wave activity for 61 to 84 hours. A healthcare professional reviews the data and provides a report. |
42 | $204 | $500 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
38 | $177 | $300 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
37 | $141 | $400 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
36 | $145 | $300 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
20 | $238 | $600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,576
Total received (2018-2024)
Avg $1,368/year across 7 years
Top 23% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
513
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,436 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$139 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,794
2023
$1,986
2022
$1,497
2021
$972
2020
$776
2019
$2,111
2018
$439
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$278
Takeda Pharmaceuticals U.S.A., Inc.
$190
Novartis Pharmaceuticals Corporation
$180
ABBVIE INC.
$164
UCB, Inc.
$161
PFIZER INC.
$97
Sumitomo Pharma America, Inc.
$75
MDD US Operations, LLC
$73
CATALYST PHARMACEUTICALS, INC.
$70
Vanda Pharmaceuticals Inc.
$68
Boston Scientific Corporation
$56
EMD Serono, Inc.
$49
Celgene Corporation
$48
Lilly USA, LLC
$40
Grifols USA, LLC
$37
ARGENX US, INC.
$32
Lundbeck LLC
$31
Amgen Inc.
$27
Kyowa Kirin, Inc.
$25
ANI Pharmaceuticals, Inc.
$23
ACADIA Pharmaceuticals Inc
$20
NEUROPACE, INC.
$18
LivaNova USA, Inc.
$17
Biogen, Inc.
$16
Top 3 companies account for 36.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$849
Boston Scientific Corporation
$798
Alexion Pharmaceuticals, Inc.
$713
UCB, Inc.
$691
ABBVIE INC.
$606
Vertiflex, Inc.
$571
Biogen, Inc.
$489
Supernus Pharmaceuticals, Inc.
$441
Medtronic USA, Inc.
$406
EMD Serono, Inc.
$340
Allergan, Inc.
$329
Amgen Inc.
$298
Janssen Pharmaceuticals, Inc
$278
Takeda Pharmaceuticals U.S.A., Inc.
$234
PFIZER INC.
$181
MDD US Operations, LLC
$154
AbbVie Inc.
$149
CSL Behring
$136
MicroVention, Inc.
$133
SK Life Science, Inc.
$115
Lilly USA, LLC
$108
Teva Pharmaceuticals USA, Inc.
$99
Grifols USA, LLC
$94
BOSTON SCIENTIFIC CORPORATION
$92
Allergan Inc.
$84
Neurocrine Biosciences, Inc.
$82
Sumitomo Pharma America, Inc.
$75
Lundbeck LLC
$73
LivaNova USA, Inc.
$71
CATALYST PHARMACEUTICALS, INC.
$70
Vanda Pharmaceuticals Inc.
$68
Celgene Corporation
$64
ARGENX US, INC.
$59
AbbVie, Inc.
$58
EISAI INC.
$51
Eisai Inc.
$49
Kyowa Kirin, Inc.
$41
Biohaven Pharmaceutical Holding Company Ltd.
$38
ACADIA Pharmaceuticals Inc
$35
Sunovion Pharmaceuticals Inc.
$34
Biohaven Pharmaceuticals, Inc.
$28
Neurelis, Inc.
$27
GE HEALTHCARE
$26
ANI Pharmaceuticals, Inc.
$23
Acorda Therapeutics, Inc
$23
Arbor Pharmaceuticals, Inc.
$23
Horizon Therapeutics plc
$20
Medtronic, Inc.
$19
MITSUBISHI TANABE PHARMA AMERICA, INC.
$19
NEUROPACE, INC.
$18
Abbott Laboratories
$18
Cardinal Health 200, LLC
$16
Merck Sharp & Dohme Corporation
$16
Upsher-Smith Laboratories LLC
$15
GENZYME CORPORATION
$13
Assertio Therapeutics, Inc.
$11
Travere Therapeutics, Inc.
$2
Top 3 companies account for 24.7% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · BOTOX · BOTOX COSMETIC · Briviact · COPAXONE · Cholbam · DAYBUE · DUOPA · Duopa · EMGALITY · FYCOMPA · Fintepla · Fixate · Fycompa · GAMMAGARD · GENERAL DBS · GOCOVRI · Gamunex-C · General - Pain Management · Gocovri · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEYTRUDA · KYPHON Balloon Kyphoplasty · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NORTHERA · NOURIANZ · NUPLAZID · NURTEC ODT · Neupro · Nourianz · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OXTELLAR XR · PANZYGA · PLEGRIDY · PONVORY · PRECISE PRO RX Carotid Stent System · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · RNS Neurostimulator Kit · Rebif · Rystiggo · SOLIRIS · Soliris · Superion ISS · Superion Indirect Decompression System · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WEB · XARELTO · ZEPOSIA · ZIPSOR · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
10
Per 100K population
0.5
County median income
$82,184
Nearest hospital
PROVIDENCE ST MARY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a clinical cardiology specialist, with above-average Medicare volume (top 28% in CA), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Patel performed 352 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $9,576 from 57 companies across 513 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other neurologists in Apple Valley?
Dr. Patel's average Medicare payment per service is $132. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Apple Valley
Browse neurologists in Apple Valley ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology